| HCVAX | ONCFX | HCVAX / ONCFX | |
| Total Expense Ratio | 1.01 | 0.67 | 151% |
| Annual Report Gross Expense Ratio | 1.01 | 0.67 | 151% |
| Fund Existence | 22 years | 29 years | - |
| Gain YTD | 1.006 | 0.991 | 101% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 1000000 | 0% |
| Min. Initial Investment IRA | 2000 | 1000000 | 0% |
| Net Assets | 143M | 4.43B | 3% |
| Annual Yield % from dividends | 3.15 | 3.43 | 92% |
| Returns for 1 year | 10.61 | 8.83 | 120% |
| Returns for 3 years | 27.31 | 22.06 | 124% |
| Returns for 5 years | 15.84 | 11.91 | 133% |
| Returns for 10 years | 64.66 | 44.28 | 146% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PDEQX | 22.20 | 0.34 | +1.56% |
| PGIM Jennison Emerging Markets Eq OppsR6 | |||
| CRMMX | 23.05 | 0.13 | +0.57% |
| CRM Mid Cap Value Inv | |||
| TEDRX | 31.29 | 0.01 | +0.03% |
| Franklin Mutual Global Discovery R | |||
| GSAFX | 28.86 | -0.04 | -0.14% |
| Goldman Sachs China Equity R6 | |||
| LAVVX | 17.21 | -0.07 | -0.41% |
| Lord Abbett Fundamental Equity R6 | |||